ABT logo

Abbott Laboratories (ABT) Long Term Liabilities

Annual Total Long Term Liabilities

N/A

December 1, 2024


Summary


Performance

ABT Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherABTbalance sheetmetrics:

Quarterly Long Term Liabilities

N/A

December 1, 2024


Summary


Performance

ABT Quarterly Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherABTbalance sheetmetrics:

Long Term Liabilities Formula

Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities

ABT Long Term Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year--
3 y3 years--
5 y5 years--

ABT Long Term Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year
5 y5-year
alltimeall time

Abbott Laboratories Long Term Liabilities History

DateAnnualQuarterly
Sep 2024
-
$19.43 B(-1.4%)
Jun 2024
-
$19.70 B(+1.5%)
Mar 2024
-
$19.40 B(-5.6%)
Dec 2023
$20.55 B(-6.8%)
$20.55 B(-3.8%)
Sep 2023
-
$21.35 B(-1.1%)
Jun 2023
-
$21.60 B(-2.0%)
Mar 2023
-
$22.03 B(-0.1%)
Dec 2022
$22.04 B(-15.4%)
$22.04 B(-6.4%)
Sep 2022
-
$23.55 B(-6.1%)
Jun 2022
-
$25.09 B(-2.5%)
Mar 2022
-
$25.73 B(-1.3%)
Dec 2021
$26.07 B(-5.7%)
$26.07 B(-0.8%)
Sep 2021
-
$26.29 B(-1.3%)
Jun 2021
-
$26.63 B(+0.3%)
Mar 2021
-
$26.54 B(-4.0%)
Dec 2020
$27.64 B(+7.4%)
$27.64 B(+1.6%)
Sep 2020
-
$27.19 B(+0.6%)
Jun 2020
-
$27.02 B(+5.8%)
Mar 2020
-
$25.54 B(-0.7%)
Dec 2019
$25.72 B(-6.3%)
$25.72 B(-1.2%)
Sep 2019
-
$26.03 B(-5.2%)
Jun 2019
-
$27.47 B(+0.4%)
Mar 2019
-
$27.37 B(-0.3%)
Dec 2018
$27.44 B(-24.3%)
$27.44 B(-1.9%)
Sep 2018
-
$27.96 B(-2.5%)
Jun 2018
-
$28.69 B(-5.3%)
Mar 2018
-
$30.30 B(-16.4%)
Dec 2017
$36.24 B(+43.3%)
$36.24 B(+12.9%)
Sep 2017
-
$32.09 B(-1.4%)
Jun 2017
-
$32.56 B(-0.4%)
Mar 2017
-
$32.69 B(+29.3%)
Dec 2016
$25.29 B(+135.6%)
$25.29 B(+146.0%)
Sep 2016
-
$10.28 B(-0.8%)
Jun 2016
-
$10.36 B(-0.4%)
Mar 2016
-
$10.40 B(-3.1%)
Dec 2015
$10.73 B(+18.0%)
$10.73 B(-8.6%)
Sep 2015
-
$11.75 B(-0.5%)
Jun 2015
-
$11.81 B(-0.7%)
Mar 2015
-
$11.90 B(+30.8%)
Dec 2014
$9.10 B(+11.3%)
$9.10 B(+4.6%)
Sep 2014
-
$8.70 B(+9.9%)
Jun 2014
-
$7.92 B(-0.9%)
Mar 2014
-
$7.99 B(-2.3%)
Dec 2013
$8.18 B(-69.9%)
$8.18 B(-9.3%)
Sep 2013
-
$9.01 B(-5.7%)
Jun 2013
-
$9.56 B(-0.4%)
Mar 2013
-
$9.60 B(-64.6%)
Dec 2012
$27.14 B(+33.9%)
$27.14 B(+36.6%)
Sep 2012
-
$19.87 B(-1.5%)
Jun 2012
-
$20.17 B(+0.4%)
Mar 2012
-
$20.09 B(-0.9%)
Dec 2011
$20.27 B(-1.3%)
$20.27 B(+3.8%)
Sep 2011
-
$19.53 B(-0.9%)
Jun 2011
-
$19.69 B(-0.1%)
Mar 2011
-
$19.71 B(-4.1%)
Dec 2010
$20.55 B(+24.8%)
$20.55 B(+1.2%)
Sep 2010
-
$20.31 B(+8.6%)
Jun 2010
-
$18.70 B(+8.9%)
Mar 2010
-
$17.16 B(+4.2%)
Dec 2009
$16.47 B(+23.7%)
$16.47 B(+3.3%)
Sep 2009
-
$15.95 B(+1.8%)
Jun 2009
-
$15.67 B(-0.1%)
Mar 2009
-
$15.68 B(+17.8%)
Dec 2008
$13.31 B(+3.7%)
$13.31 B(+3.6%)
Sep 2008
-
$12.85 B(-1.9%)
Jun 2008
-
$13.10 B(+5.4%)
Mar 2008
-
$12.43 B(-3.2%)
Dec 2007
$12.83 B(+26.1%)
$12.83 B(+31.9%)
Sep 2007
-
$9.73 B(-0.8%)
Jun 2007
-
$9.81 B(+1.5%)
Mar 2007
-
$9.66 B(-5.0%)
Dec 2006
$10.17 B
$10.17 B(-0.6%)
DateAnnualQuarterly
Sep 2006
-
$10.23 B(-8.5%)
Jun 2006
-
$11.18 B(+61.4%)
Mar 2006
-
$6.93 B(-5.2%)
Dec 2005
$7.31 B(-4.0%)
$7.31 B(+25.8%)
Sep 2005
-
$5.81 B(-21.0%)
Jun 2005
-
$7.35 B(+0.6%)
Mar 2005
-
$7.31 B(-4.0%)
Dec 2004
$7.62 B(+26.9%)
$7.62 B(+4.1%)
Sep 2004
-
$7.31 B(+1.1%)
Jun 2004
-
$7.24 B(-4.6%)
Mar 2004
-
$7.59 B(+26.4%)
Dec 2003
$6.00 B(-8.9%)
$6.00 B(-4.0%)
Sep 2003
-
$6.25 B(-6.2%)
Jun 2003
-
$6.66 B(+1.5%)
Mar 2003
-
$6.57 B(-0.4%)
Dec 2002
$6.59 B(+4.5%)
$6.59 B(+3.1%)
Sep 2002
-
$6.40 B(+1.6%)
Jun 2002
-
$6.30 B(-1.1%)
Mar 2002
-
$6.37 B(+0.9%)
Dec 2001
$6.31 B(+161.3%)
$6.31 B(+0.7%)
Sep 2001
-
$6.27 B(+1.8%)
Jun 2001
-
$6.16 B(+105.9%)
Mar 2001
-
$2.99 B(+23.8%)
Dec 2000
$2.41 B(-4.4%)
$2.41 B(+1.4%)
Sep 2000
-
$2.38 B(-8.1%)
Jun 2000
-
$2.59 B(+0.2%)
Mar 2000
-
$2.59 B(+2.4%)
Dec 1999
$2.53 B(-0.5%)
$2.53 B(-1.9%)
Sep 1999
-
$2.58 B(+1.6%)
Jun 1999
-
$2.54 B(-0.4%)
Mar 1999
-
$2.55 B(+0.2%)
Dec 1998
$2.54 B(+25.3%)
$2.54 B(-0.9%)
Sep 1998
-
$2.56 B(+8.0%)
Jun 1998
-
$2.37 B(+5.7%)
Mar 1998
-
$2.25 B(+10.8%)
Dec 1997
$2.03 B(+3.4%)
$2.03 B(+0.8%)
Sep 1997
-
$2.01 B(+1.5%)
Jun 1997
-
$1.98 B(+0.8%)
Mar 1997
-
$1.97 B(+0.3%)
Dec 1996
$1.96 B(+60.1%)
$1.96 B(+17.6%)
Sep 1996
-
$1.67 B(+20.3%)
Jun 1996
-
$1.39 B(+10.5%)
Mar 1996
-
$1.25 B(+2.4%)
Dec 1995
$1.23 B(+22.7%)
$1.23 B(-0.1%)
Sep 1995
-
$1.23 B(+1.2%)
Jun 1995
-
$1.21 B(+17.6%)
Mar 1995
-
$1.03 B(+3.2%)
Dec 1994
$998.46 M(+8.7%)
$998.46 M(+0.9%)
Sep 1994
-
$989.90 M(+3.4%)
Jun 1994
-
$957.76 M(+1.7%)
Mar 1994
-
$941.53 M(+2.5%)
Dec 1993
$918.71 M(+13.3%)
$918.71 M(+11.8%)
Sep 1993
-
$822.10 M(+10.1%)
Jun 1993
-
$746.80 M(+7.6%)
Mar 1993
-
$694.20 M(-14.4%)
Dec 1992
$811.10 M(-1.4%)
$811.10 M(-5.0%)
Sep 1992
-
$853.60 M(+1.5%)
Jun 1992
-
$841.00 M(-1.3%)
Mar 1992
-
$852.50 M(+3.6%)
Dec 1991
$823.00 M(+13.0%)
$823.00 M(+3.7%)
Sep 1991
-
$793.50 M(+0.2%)
Jun 1991
-
$792.20 M(-0.3%)
Mar 1991
-
$794.40 M(+9.0%)
Dec 1990
$728.50 M(-1.8%)
$728.50 M(-9.0%)
Sep 1990
-
$800.90 M(+3.2%)
Jun 1990
-
$775.70 M(+0.6%)
Mar 1990
-
$771.10 M(+4.0%)
Dec 1989
$741.60 M(-19.5%)
$741.60 M(-19.5%)
Dec 1988
$920.80 M(+14.3%)
$920.80 M(+14.3%)
Dec 1987
$805.40 M(+2.8%)
$805.40 M(+2.8%)
Dec 1986
$783.20 M(-3.2%)
$783.20 M(-3.2%)
Dec 1985
$809.20 M(+5.9%)
$809.20 M(+5.9%)
Dec 1984
$763.80 M
$763.80 M

FAQ

  • What is the all time high annual total long term liabilities for Abbott Laboratories?
  • What is the all time high quarterly long term liabilities for Abbott Laboratories?

What is the all time high annual total long term liabilities for Abbott Laboratories?

Abbott Laboratories all-time high annual total long term liabilities is $36.24 B

What is the all time high quarterly long term liabilities for Abbott Laboratories?

Abbott Laboratories all-time high quarterly total long term liabilities is $36.24 B